KU 210 (Montelukast sodium 10 mg (base))

Pill imprint KU 210 has been identified as Montelukast sodium 10 mg (base).

Montelukast is used in the treatment of asthma, maintenance; asthma; hay fever; bronchospasm prophylaxis; copd and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Montelukast 10 mg (base) is not subject to the Controlled Substances Act.

See also related documents.

Images for KU 210 (Montelukast sodium 10 mg (base))

Montelukast sodium
Imprint:
KU
210
Strength:
10 mg (base)
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Leukotriene modifiers
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Kremers Urban Pharmaceuticals Inc.
National Drug Code (NDC):
62175-0210
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
hydroxypropyl cellulose (type h)
mannitol
microcrystalline cellulose
polyethylene glycol
polyvinyl alcohol
sodium stearyl fumarate
magnesium silicate
titanium dioxide

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Watch this video series to learn about managing severe allergies (anaphylaxis).

Close
Hide
(web3)